The only penny stocks site recommended in Barron's and by Forbes.

Online since 1996, we pick stocks trading at under $5.00 that are listed on the NYSE, NASDAQ, and AMEX.

To learn what this site is really about, we urge you to visit the Overview and Track Record pages. However, before doing so, take a glance at a few of our all-time penny stocks winners. Of course, these are the subsequent gains reached once they hit our target prices and we closed the positions, but it is fun to ponder. The first price was the initial recommendation, followed by the subsequent high, and the eventual ultimate percentage gain. No doubt, you will recognize most of these companies.

Netegrity
(acquired by IBM)
$2.18 to $73.20 3487%
Inhibitex
(acquired by BristolMyersSquibb)
$2.35 to $24.08 925%
Cellstar $1.44 to $13.50 837%
Iomega $3.25 to $13.90 328%
Nanophase $3.75 to $16.75 347%
Immunomedics $1.44 to $29.12 1922%
Total Renal Care $3.12 to $26.95 741%
Voxware $ .90 to $10.31 1046%
Corvas $3.00 to $23.25 675%
Cytogen $2.12 to $17.50 725%
Verilink $3.00 to $14.62 387%
GeneLabs $2.31 to $10.72 364%

WE CLOSED ADMA BIOLOGICS AT $6.10 FOR A 85% GAIN!

WE CLOSED CURIS, INC. AT $2.62 FOR A 80% GAIN!

WE CLOSED ANAVEX LIFE SCIENCES AT $3.95 FOR A 56% GAIN!

ALSO, WE CLOSED CATALYST PHARMACEUTICALS AT $5.24 FOR A 54% GAIN!

AND, WE CLOSED NEOS THERAPEUTICS AT $3.60 FOR A 71% GAIN!

The mid to late April Newsletter is now live and featured are EVEN TWO MORE BIOTECH picks, both trading at around $2.75.  One specializes in gene therapies and has collaborations with around half dozen institutions, including MIT; while the other, a CHANNELED STOCK PICK, that worked wonders for us before, develops products to improve biodefenses.

The early to mid-May Newsletter will feature a maker of anti-infective agents that has recently had two NDAs granted by the FDA, trading at around $2.75; while the other pick develops therapies for GI diseases and is a BUY of SEVEN ANALYSTS and trades at about $3.55. 

 

"I cannot thank you enough for your excellent newsletter... I do believe I have found a new hobby (and a well paying one, at that), thanks to you!"

— B.K. (Contractor in Saudi Arabia)

See what our subscribers have to say...

 
New! Join our Penny Stocks Forum
(Note: this is separate from the Newsletter)

Ads From Google

"I cannot thank you enough for your excellent newsletter... I do believe I have found a new hobby (and a well paying one, at that), thanks to you!"

— B.K. (Contractor in Saudi Arabia)

See what our subscribers have to say...

Forbes Directory - Best of the Web
Best of the Web
(Small Caps)
Barron's > read
review
As Featured:
*BARRON's
*CNNfn.com
*BusinessWeek Online
*Barron's Electronic Edition
InvestOnlineTrading

Ads From Google

"I cannot thank you enough for your excellent newsletter... I do believe I have found a new hobby (and a well paying one, at that), thanks to you!"

— B.K. (Contractor in Saudi Arabia)

See what our subscribers have to say...


The only penny stocks site recommended in Barron's and by Forbes, we pick stocks trading at under $5.00 that are listed on the NYSE, NASDAQ, and AMEX. Penny stock trading involves substantial risk, so always research every recommendation before trading, consult with licensed professionals before trading, and always trade with caution. The recommendations listed in the Newsletter are only for investment ideas and are not solicitations to purchase equities. For more extensive details, view the Privacy Policy and Disclaimer page.
Ads From Google